Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Operating Expenses | 1,637 | 5,872 | 36 | 20 | 11 |
| Operating Income | -1,637 | -5,722 | -36 | -20 | -11 |
| Other Income | 41 | 31 | 4 | 8 | 1 |
| Pre-tax Income | -1,596 | -5,691 | -32 | -13 | -10 |
| Net Income Continuous | -1,596 | -5,691 | -32 | -13 | -10 |
| Net Income | $-1,559 | $-5,691 | $-32 | $-13 | $-10 |
| EPS Basic Total Ops | -0.80 | -2.10 | -1.00 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.85 | -1.21 | -1.10 | -0.44 | -0.36 |
| EPS Diluted Total Ops | -0.80 | -2.10 | -1.00 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.85 | -1.21 | -1.10 | -0.44 | -0.36 |
| EBITDA(a) | $-1,539 | $-5,872 | $-36 | $-20 | $-11 |